Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Autolus Therapeutics Plc ADR (NQ: AUTL ) 4.350 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Autolus Therapeutics Plc ADR < Previous 1 2 3 4 5 6 Next > Autolus Therapeutics' Leukemia Trial Meets Primary Goal Of Remission Rate, Shares Fall After $150M Capital Raise December 09, 2022 Via Benzinga Why Autolus Therapeutics Shares Are Trading Lower By Around 26%; Here Are 28 Stocks Moving Premarket December 09, 2022 Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares rose 48.2% to $6.03 in pre-market trading after jumping over 20% on Thursday. Baudax Bio initiated Phase II clinical trial evaluating BX1000 in patients... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday December 09, 2022 The trading week is almost complete but we've still got the biggest pre-market stock movers to go over for Friday morning! Via InvestorPlace Autolus Therapeutics: Q3 Earnings Insights November 03, 2022 Autolus Therapeutics (NASDAQ:AUTL) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga Moderna In-Licenses Autolus' Technology For mRNA-Based Cancer Therapeutics October 12, 2022 Via Benzinga Recap: Autolus Therapeutics Q2 Earnings August 04, 2022 Autolus Therapeutics (NASDAQ:AUTL) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga Autolus Announces Pricing of Public Offering December 08, 2022 From Autolus Therapeutics plc Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's After-Market Session December 08, 2022 Via Benzinga Autolus Announces Proposed Public Offering in the United States December 08, 2022 From Autolus Therapeutics plc Via GlobeNewswire Earnings Scheduled For March 10, 2022 March 10, 2022 Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares... Via Benzinga Autolus Therapeutics to Receive $70 Million in Milestone Payments from Blackstone Life Sciences December 08, 2022 From Autolus Therapeutics plc Via GlobeNewswire Autolus Therapeutics announces pivotal Phase 2 FELIX clinical trial has met primary endpoint at interim analysis December 08, 2022 From Autolus Therapeutics plc Via GlobeNewswire Autolus Therapeutics announces handover of first clean rooms of new Stevenage, UK, manufacturing facility November 30, 2022 From Autolus Therapeutics plc Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's After-Market Session November 15, 2022 Via Benzinga Autolus Therapeutics to Present Three Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2022 November 03, 2022 From Autolus Therapeutics plc Via GlobeNewswire Autolus Therapeutics Reports Third Quarter 2022 Financial Results and Operational Progress November 03, 2022 From Autolus Therapeutics plc Via GlobeNewswire Autolus Therapeutics to Report Third Quarter 2022 Financial Results on November 3, 2022 October 21, 2022 From Autolus Therapeutics plc Via GlobeNewswire Moderna exercises option to license proprietary targeting technology from Autolus October 12, 2022 From Autolus Therapeutics plc Via GlobeNewswire R&D Efforts to Improve Optimal Treatments for Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Progressing October 05, 2022 Palm Beach, FL – October 5, 2022 – FinancialNewsMedia.com News Commentary – Advanced pancreatic ductal adenocarcinoma (PDAC) remains a significant cause of mortality accounting for up to 4% of all... Via FinancialNewsMedia Topics Death Exposures Death 11 Health Care Stocks Moving In Wednesday's Pre-Market Session October 05, 2022 Gainers Bionano Genomics (NASDAQ:BNGO) stock increased by 9.8% to $2.24. The company's market cap stands at $649.9 million. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday October 05, 2022 It's time for another overview of the biggest pre-market stock movers for Wednesday as we cover the news behind share movement this morning! Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Intraday Session October 04, 2022 Gainers Via Benzinga Autolus Therapeutics Stock Jumps After Bristol Myers Pact For Safety Switch System October 04, 2022 Via Benzinga Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session October 04, 2022 Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday. Via Benzinga Autolus Therapeutics Announces Collaboration with Bristol Myers Squibb for Use of Autolus’ Proprietary Safety Switch System October 04, 2022 From Autolus Therapeutics plc Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session September 21, 2022 Gainers Scopus BioPharma (NASDAQ:SCPS) stock moved upwards by 10.9% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.3 million. Via Benzinga The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study May 05, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Recap: Autolus Therapeutics Q4 Earnings March 10, 2022 Autolus Therapeutics (NASDAQ:AUTL) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... Via Benzinga The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg March 06, 2022 Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (... Via Benzinga 58 Biggest Movers From Yesterday December 14, 2021 Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-... Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.